Professional Documents
Culture Documents
Ahmed AL-Arwali
Pharmacology of Chemotherapy
Principles of therapy
Definition of Chemotherapy:
Is the term used to describe the use of drugs that are selectively toxic to invading
micro-organisms while having minimal effects on the host. Also this term used to
embraces the use of drugs that target tumor (cancer).
Antibacterial Dugs
- Lactams
Penicillins
Mechanism of Action:
Bacterial Cell Wall inhibition
Activity: against Gram +ve bacteria e.g.: Niesseria, Bacillus anthracis, Treponema
palladium, collstridium prefrings, C. Tetani, Corynebacterium diphtheriaetc.
Clinical Use:
Acute RTI (respiratory tract infection), syphilis, tetanus, diphtheria and anthrax.
Dose:
1-5 million Unit per 6 hours, IV,IMor IV infusion.
2.
3.
4.
Narrow spectrum(for Gm+ve not Gm-ve) not effective against gram ve e.g.
E.coi, H.infl., H.pylor, shigella and salmonella.
o From 2nd week till 4th week the drug level is prophylactic.
Activity:
Same as penicillin G
Clinical use:
Same as penicillin G and bacterial artheritis.
Activity:
Same as penicillin G
Clinical Use:
Mild RTI.
Activity:
3
.
Clinical Use:
RTI.
Activity:
Same as Penicilline G and gram ve species e.g. salmonella, shigella, H.Pylori,
HH.Influenza and E.Coli.
Clinical Use:
RTI, UTI & typhoid.
1.
2.
Ampicillin:
Pro-Ampicillin(esters of ampicillin):
3.
Amoxicillin:
B-lactmase inhibitors:
They havent antibacterial effect or its minimal.
They bind to the enzyme, cause irreversible inhibition for the enzyme(suicide
substrate).
Protect B-lactams from the bacteria enzyme of PEPSI(Proteus, E.Coli,
Pseudomonas, Staph. & H.Infleunza).
B-lactamase inhibitor
Combined penicillin
Route.
Clavulanic Acid
Amoxicillin
Sulbactam
Ampicillin
Tazobactam
piperacillin
Parenteral
Broad spectrum + Pseudomonas & proteus (B-lactmase sensitive so we ad Blactamase inhibitors see the previous table-)
1.
Ureido Penicillin:
2.
3.
4.
5.
6.
Skin Rash(Ampicillin).
7.
Bleeding(Carboxy penicillins).
Cephalosporins are used to treat infections caused by sensitive organisms. As with other
antibiotics, patterns of sensitivity vary geographically, and treatment is often started
empirically. Many different kinds of infection may be treated, including:
o - septicaemia (e.g. cefuroxime, cefotaxime)
o - pneumonia caused by susceptible organisms
o - meningitis (e.g. ceftriaxone, cefotaxime)
o - biliary tract infection
o - urinary tract infection (especially in pregnancy or in patients unresponsive to other
drugs)
o - sinusitis (e.g. cefadroxil).
Antibacterial spectrum
Cephalosporins have been classified as first, second, third, and fourth generation,
based largely on their bacterial susceptibility patterns and resistance to lactamases [Note: Commercially available cephalo sporins are ineffective against
MRSA, L. monocytogenes, Clostri dium difficile, and the enterococci.]
Clinical Uses
First-Generation Drugs
Cefazolin (parenteral) and cephalexin (oral) are examples of this subgroup. They
are active against gram-positive cocci, including staphylococci and common
streptococci. Many strains of E coli and K pneumoniae are also sensitive. Clinical
uses include treatment of infections caused by these organisms and surgical
prophylaxis in selected conditions. These drugs have minimal activity against
gram-negative cocci, enterococci, methicillin-resistant staphylococci, and most
gram-negative rods.
Second-Generation Drugs
Drugs in this subgroup usually have slightly less activity against gram-positive
organisms than the first-generation drugs but have an extended gram-negative
coverage. Marked differences in activity occur among the drugs in this subgroup.
7
.
Third-Generation Drugs
Characteristic features of third-generation drugs (eg, ceftazidime,cefoperazone,
cefotaxime ) include increased activity against gram-negative organisms resistant
to other beta-lactam drugs and ability to penetrate the blood-brain barrier (except
cefoperazone and cefixime). Most are active against Providencia,Serratia
marcescens, and beta-lactamase-producing strains of H influenzae and Neisseria;
they are less active against Enterobacter strains that produce extended-spectrum
beta-lactamases. Ceftriaxone and cefotaxime are currently the most active
cephalosporins against penicillin-resistant pneumococci (PRSP strains), but
resistance is reported. Individual drugs also have activity against
Pseudomonas(cefoperazone, ceftazidime) and B fragilis ( ceftizoxime ). Drugs in
this subclass should usually be reserved for treatment of serious infections.
Ceftriaxone (parenteral) and cefixime (oral), currently drugs of choice in
gonorrhea, are exceptions. Likewise, in acute otitis media, a single injection of
ceftriaxone is usually as effective as a 10-day course of treatment with amoxicillin.
Fourth-Generation Drugs
Cefepime is more resistant to beta-lactamases produced by gram-negative
organisms, including Enterobacter, Haemophilus, Neisseria, and some penicillinresistant pneumococci. Cefepime combines the gram-positive activity of firstgeneration agents with the wider gram-negative spectrum of third-generation
cephalosporins.
Adverse effects :
1.
2.
3.
8
.
Macrolides
Drug
Antimicrobial activity
Use
Erythromycin
anorexia, N,V,D,
Streptococci, Pneumococci,
acquired pneumonia,
RTI, endocarditis
prophylaxis in dental
procedures, pertussis,
similar
oral
less GIT SE
chlamydial infections,
O/P
community acquired
pneumonia, gonorrhea
Toxoplasma gondii
toxoplasmosis during
Clarithromycin
Route SE
Comments
alternative to penicillins
M leprae
Azithromycin
Spiramycin
pregnancy
no drug interactions
oral
Aminoglycosides
Drug
Antimicrobial activity
Use
Route SE
Comments
Streptomycin
vestibular toxicity,
tularensis
plague, tularemia,
nephrotoxicity
ototoxicity,
and brucellosis
Gentamicin
pneumonia, UTI
Amikacin
Tobramycin
interchangeable with
against pseudomonas
gentamicin clinically
wounds
Neomycin
Kanamycin
Spectinomycin
Paromomycin
Entamoeba histolytica
penicillin-resistant
T/O
parenteral use
IM
gonorrhea
nephrotoxicity
dose 40 mg/kg ~ 2 g
abdominal distress,
diarrhea
10
Quinolones
Drug
Activity
frequency CU
Comments
Ciprofloxacin
bid
UTI, GITI ,
gram positive
bacteria
aeruginosa
gram positive =
od
gram negative
pneumonia
bacteria
or hyperglycemia
Gemifloxacin
od
Levofloxacin
od
also tuberculosis
Lomefloxacin
as ciprofloxacin
od
as ciprofloxacin
Moxifloxacin
as gatifloxacin
od
against anaerobic
bacteria
hepatic elimination
Norfloxacin
bid
UTI
gram positive
no adequate systemic
concentrations
as ciprofloxacin
Nalidixic acid
gram negative
bid
UTI
UTI
no systemic effect
bacteria
MOA
Activity
in addition to above all quinolones except nalidixic acid are active against
mycoplasmas,chlamydiae, Legionella sp., M tuberculosis, M avium
CI
11
Sulfonamides
Drug
Sulfacytine
prompt short
oral
UTI
Sulfisoxazole
short 6 h
Sulfamethazine
short 7 h
Sulfamethizole
short 9 h
Sulfamerazine
short
slow
intermediate 10-17 h
intermediate 10-12 h
Sulfadiazine
Sulfamethoxazole
Sulfadoxine
Sulfacetamide
Sulfapyridine
short 7 h
slow
intermediate 17 h
dermatitis herpetiformis
prompt intermediate
UTI, prostatitis
Pyrimethamine
slow
malaria
MOA
Activity